Safety Assessment and Pharmacodynamics of a Novel Ultra Low Molecular Weight Heparin (RO-14) in Healthy Volunteers – A First-Time-In-Human Single Ascending Dose Study-Reference-Cited by-同舟云学术

Safety Assessment and Pharmacodynamics of a Novel Ultra Low Molecular Weight Heparin (RO-14) in Healthy Volunteers – A First-Time-In-Human Single Ascending Dose Study

Published:2011-04 Issue:4 Volume:127 Page:292-298
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Rico Salvador,Antonijoan Rosa Maria,Gich Ignasi,Borrell Montserrat,Fontcuberta Jordi,Monreal Mayte,Martinez-Gonzalez Javier,Barbanoj Manel J.

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Mechanisms of thrombus formation;Furie;N Engl J Med,2008

2. Low-molecular-weight heparins;Weitz;N Engl J Med,1997

3. Heparin and low-molecular-weight heparin;Gray;Thromb Haemost,2008

4. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Hirsh;Chest,2004

5. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Kearon;Chest,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbohydrate‐Based Antithrombotics;Carbohydrate‐Based Therapeutics;2023-09-05

2. Anticoagulation Management during Extracorporeal Membrane Oxygenation—A Mini-Review;Medicina;2022-12-03

3. The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials;Frontiers in Bioengineering and Biotechnology;2022-05-12

4. Pharmacological and clinical application of heparin progress: An essential drug for modern medicine;Biomedicine & Pharmacotherapy;2021-07

5. Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism;Inflammopharmacology;2020-11-23